
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,600 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 January 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 218 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 122 results:
[ Author
Filters: First Letter Of Last Name is L [Clear All Filters]
“Mortality in Wegener's granulomatosis: a bimodal pattern”, Rheumatology (Oxford), vol. 50, pp. 697-702, 2011.
, “Evaluation of methods to estimate missing days' supply within pharmacy data of the Clinical Practice Research Datalink (CPRD) and The Health Improvement Network (THIN)”, Eur J Clin Pharmacol, vol. 73, pp. 115-123, 2017.
“Atopic eczema and fracture risk in adults: A population-based cohort study”, J Allergy Clin Immunol, 2019.
, “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
, “Trends in the prescription of novel oral anticoagulants in UK primary care”, Br J Clin Pharmacol, vol. 83, pp. 2096-2106, 2017.
, “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
, “Development and Validation of a Clinical Prediction Tool for Seasonal Influenza Vaccination in England”, JAMA Netw Open, vol. 3, p. e207743, 2020.
, “Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: An age-stratified retrospective cohort study”, Vaccine X, vol. 4, p. 100054, 2020.
, “Incidence, prevalence and management of lower urinary tract symptoms in men in the UK”, BJU Int, vol. 95, pp. 557-62, 2005.
, “Lower urinary tract symptoms suggestive of benign prostatic obstruction–Triumph: the role of general practice databases”, Eur Urol, vol. 39 Suppl 3, pp. 42-7, 2001.
, “Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices' prescribing in England”, Bmj, vol. 311, pp. 991-4, 1995.
, “Effect of Named, Accountable GPs on Continuity of Care: Protocol for a Regression Discontinuity Study of a National Policy Change”, Int J Integr Care, vol. 16, p. 6, 2016.
, “Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study”, BMC Cancer, vol. 19, p. 1017, 2019.
, “Statin use and reduced risk of biliary tract cancers in the UK Clinical Practice Research Datalink”, Gut, 2018.
, “Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis”, BMJ Open, vol. 7, p. e012665, 2017.
, “Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome”, Genes (Basel), vol. 9, 2018.
, “A concurrent cohort study of oral contraceptive users from the VAMP research bank”, Pharmacoepidemiology and Drug Safety, vol. 2, pp. 51-63, 1993.
, “Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data”, Schizophr Res, vol. 154, pp. 54-60, 2014.
, “Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom”, J Am Heart Assoc, vol. 8, p. e012655, 2019.
, “Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK”, ESC Heart Fail, 2019.
, “Performance characteristics of visualising the cervix in symptomatic young females: a review of primary care records in females with and without cervical cancer”, Br J Gen Pract, vol. 66, pp. e189-92, 2016.
, “Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review”, Br J Gen Pract, vol. 66, pp. e871-e879, 2016.
, “Estimating individualized optimal combination therapies through outcome weighted deep learning algorithms”, Stat Med, vol. 37, pp. 3869-3886, 2018.
, “Semi automated transformation to OWL formatted files as an approach to data integration. A feasibility study using environmental, disease register and primary care clinical data”, Methods Inf Med, vol. 54, pp. 32-40, 2015.
, “Increased risk of subsequent myocardial infarction in patients with type 2 diabetes: a retrospective cohort study using the U.K. General Practice Research Database”, Diabetes Care, vol. 37, pp. 1329-37, 2014.
, “Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom”, Medicine (Baltimore), vol. 96, p. e7116, 2017.
, “Monitoring for proteinuria in patients with type 2 diabetes mellitus”, BMJ Open Diabetes Res Care, vol. 3, p. e000071, 2015.
, “Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer”, Eur Urol, vol. 70, pp. 808-815, 2016.
, “Relationship between prescribing of antibiotics and other medicines in primary care: a cross-sectional study”, Br J Gen Pract, vol. 69, pp. e42-e51, 2019.
, “Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?”, Sci Rep, vol. 9, p. 11222, 2019.
, “Consistency of variety of machine learning and statistical models in predicting clinical risks of individual patients: longitudinal cohort study using cardiovascular disease as exemplar”, Bmj, vol. 371, p. m3919, 2020.
, “BEHRT: Transformer for Electronic Health Records”, Sci Rep, vol. 10, p. 7155, 2020.
, “Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease”, Int J Med Inform, vol. 133, p. 104033, 2020.
, “Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis”, J Cancer Epidemiol, vol. 2012, p. 291704, 2012.
, “Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 56, pp. 753-762, 2017.
, “Opioid use for noncancer pain and risk of fracture in adults: a nested case-control study using the general practice research database”, Am J Epidemiol, vol. 178, pp. 559-69, 2013.
, “Opioid use for noncancer pain and risk of myocardial infarction amongst adults”, J Intern Med, vol. 273, pp. 511-26, 2013.
, “Opioids and risk of type 2 diabetes in adults with non-cancer pain”, Pain Physician, vol. 16, pp. 77-88, 2013.
, “Persistence with osteoporosis medications among postmenopausal women in the UK General Practice Research Database”, Menopause, vol. 19, pp. 33-40, 2012.
, “Mortality in Patients With Giant Cell Arteritis: A Cohort Study in UK Primary Care”, Arthritis Care Res (Hoboken), vol. 70, pp. 1251-1256, 2018.
, “A cohort study of comorbidity in patients with granulomatosis with polyangiitis”, Rheumatology (Oxford), vol. 57, pp. 291-299, 2018.
, “Rates of Cardiovascular Disease and Major Adverse Cardiovascular Events in Patients With Psoriatic Arthritis Compared to Patients Without Psoriatic Arthritis”, J Clin Rheumatol, vol. 21, pp. 405-10, 2015.
, “Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus”, Eur J Prev Cardiol, vol. 21, pp. 855-65, 2014.
, “Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the U.K. General Practice Research Database”, Menopause, vol. 21, pp. 1106-13, 2014.
, “Validity of non-fatal idiopathic serious ventricular arrhythmia in UK-based Clinical Practice Research Datalink”, Pharmacoepidemiol Drug Saf, vol. 23, pp. 999-1001, 2014.
, “Health impacts of increasing alcohol prices in the European Union: a dynamic projection”, Prev Med, vol. 55, pp. 237-43, 2012.
, “DYNAMO-HIA–a Dynamic Modeling tool for generic Health Impact Assessments”, PLoS One, vol. 7, p. e33317, 2012.
, “Inflammatory bowel disease is not associated with an increased risk of lymphoma”, Gastroenterology, vol. 121, pp. 1080-7, 2001.
, “Immunosuppressant medications and mortality in inflammatory bowel disease”, Am J Gastroenterol, vol. 103, pp. 1428-35; quiz 1436, 2008.
, “Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 211-8, 2002.
,